Pinak Joshi

Pinak Joshi has extensive work experience in various medical and bioengineering roles. Pinak started their career in 2018 as a Clinical Pathologist at Harvard Medical School and Massachusetts General Hospital, where they worked until 2021. In 2020, they also worked as a Drug Safety professional at the National Cancer Institute. From 2020 to 2021, they were involved in Private Equity at Vectors Capital. In 2021, they joined CareDx, Inc. as part of the Medical Affairs team until 2023. In 2022, they took on the role of Professor in Bioengineering at Regis College. Currently, Pinak Joshi is serving as the Medical Director at OrganOx starting in 2023.

Pinak Joshi holds a Master of Business Administration (MBA) degree from the Quantic School of Business and Technology. Pinak also obtained a Doctor of Medicine (M.D.) degree from St. George's University, specializing in Medicine. Pinak further pursued a Master's degree in Clinical and Industrial Drug Development from the University of South Florida. Pinak completed their undergraduate education at the University of Wisconsin-Madison, earning a Bachelor's degree in Molecular Biology.

In addition to their formal education, Pinak Joshi has obtained several certifications. Pinak is a Board Certified Medical Affairs Specialist from the Accreditation Council for Medical Affairs (ACMA), which they achieved in October 2021. Pinak also holds the designation of Qualified Professional In Drug Safety from the InnoVigilance International Academy™, although the specific month and year when they obtained this certification are not provided.